CMPX - Compass Therapeutics, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts7777
Avg. Estimate-0.08-0.09-0.34-0.47
Low estimate-0.1-0.11-0.4-0.64
High estimate-0.07-0.07-0.26-0.33
Year ago EPS-0.08-0.12-0.37-0.34
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5555
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.08-0.11-0.11-0.11
Actual EPS-0.08-0.12-0.1-0.06
Difference0-0.010.010.05
Surprise %0.00%-9.10%9.10%45.50%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.08-0.09-0.34-0.47
7 days ago-0.08-0.09-0.34-0.47
30 days ago-0.12-0.12-0.47-0.59
60 days ago-0.12-0.12-0.47-0.59
90 days ago-0.12-0.12-0.48-0.59
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days7677
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCMPXIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.25.00%N/AN/AN/A
Current year8.10%N/AN/AN/A
Next year-38.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A